Clinical Trials Logo

Treatment-resistant Bipolar Depression clinical trials

View clinical trials related to Treatment-resistant Bipolar Depression.

Filter by:
  • None
  • Page 1

NCT ID: NCT03522545 Not yet recruiting - Clinical trials for Treatment-resistant Bipolar Depression

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression

Start date: June 1, 2018
Phase: Phase 1
Study type: Interventional

Our overall objective is to assess the therapeutic efficacy and tolerability of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) isolated from hematogenous bone marrow for treatment of treatment-resistant bipolar depression patient (TRBD).